Home -> Law Blog Directory -> Legal News Blogs -> Lawyers and Settlements
OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Legal News
: Lawyers and SettlementsA Life in Limbo
ADVERTISEMENTS
Tiffin, OH: Shelva's husband, Raymond, had to go to hospital recently to have his stent replaced. Raymond has taken Vytorin for two years, and began taking the block-buster anti-cholesterol drug just before he had is original stent put in. According to the claims of the makers of Vytorin, Raymond's cholesterol should have been reduced, so much so in fact that he wouldn't need a new stent in such short order, if at all. But that's not what happened. Vytorin didn't reduce either Raymond's cholesterol levels, or those of his wife, who was also taking the drug.Full post as published by Lawyers and Settlements on April 19, 2008 (boomark / email).
Lawsuits and Settlements
Great-West Lifeco Must Pay $456 Million In London Life Class Action
Great-West Lifeco Must Pay $456 Million In London Life Class Action
Nestle
Pure Life Water Recall
Fake Drugs
Life Threatening Incidents
Aetna Life Insurance
Houston Woman Denied $426,000
US Coast Guard
Switlik Marine Life Rafts Recalled
American Equity Investment Life
Settles Class Action
Related Searches
Are you the author of this blog? Adding USLaw.com to your Blogroll increases relevance. You qualify to display a USLaw Network badge.
Suggest changes to this blog's description or nominate another for inclusion. Register for updates.

Indecency cases stuck in legal limbo at FCC
Dr. Al-Arian Remains in Limbo After Completion of Sentence
To Exiled from the Book of Bootstraps Verses 1-12
Goldman Sach Cancels a Deal: SPACs in Limbo









